Bernard et al. proposed a novel indicator, the neutrophil percentage-to-albumin ratio (NPAR), that combines peripheral neutrophil percentage and serum albumin concentration; they reported its prognostic significance in patients with rectal cancer who underwent neoadjuvant chemoradiotherapy followed by surgery [13]. Here, ALB is linked to rectal cancer.